INVITRO GRANULOPOIESIS IN MYELODYSPLASTIC SYNDROMES (MDS) ACCORDING TO THE FAB CLASSIFICATION

被引：0
|
作者：
FLORENSA, L [1 ]
WOESSNER, S [1 ]
LAFUENTE, R [1 ]
BUXO, J [1 ]
ALMARCHA, J [1 ]
MARILL, MR [1 ]
SANSSABRAFEN, J [1 ]
机构：
[1] HOSP CREU ROJA,UNIDAD HEMATOL & ONCOL,E-08025 BARCELONA,SPAIN
来源：
BLUT | 1988年 / 56卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：C20 / C20
页数：1
相关论文
共 50 条
  • [21] WHO CLASSIFICATION 2016 FOR THE MYELODYSPLASTIC SYNDROMES (MDS): MAIN CHANGES
    Strupp, C.
    Aul, C.
    Germing, U.
    LEUKEMIA RESEARCH, 2017, 55 : S77 - S77
  • [22] WHO classification 2016 for the myelodysplastic syndromes (MDS): how to proceed
    Germing, U.
    Strupp, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 215 - 215
  • [23] Correlation Between Dysplastic Lineage and Type of Cytopenia in Myelodysplastic Syndromes Patients With Refractory Anemia According to the FAB Classification
    Matsuda, Akira
    Jinnai, Itsuro
    Iwanaga, Masako
    Okamura, Daisuke
    Ishikawa, Maho
    Maeda, Tomoya
    Hata, Tomoko
    Kawai, Nobutaka
    Miyazaki, Yasushi
    Bessho, Masami
    Tomonaga, Masao
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 (02) : 253 - 257
  • [24] Update on myelodysplastic syndromes (MDS)
    Hector Rodriguez, Jose
    del Lujan Acosta, Irma
    REVISTA MEDICA DE ROSARIO, 2011, 77 (01): : 24 - 41
  • [25] Rigosertib in myelodysplastic syndromes (MDS)
    Raza, A.
    Ali, A. M.
    Reddy, M. V. R.
    Hoffman, B. S.
    Petrone, M. E.
    Maniar, M.
    Pinheiro, R. F.
    Coutinho, D. F.
    Fruchtman, S. M.
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (09): : 981 - 988
  • [26] MYELODYSPLASTIC SYNDROMES - ANALYSIS OF MORPHOLOGICAL FEATURES RELATED TO THE FAB-CLASSIFICATION
    VANDERWEIDE, M
    SIZOO, W
    KREFFT, J
    LANGENHUIJSEN, MMAC
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1988, 41 (01) : 58 - 61
  • [27] The pathogenesis of myelodysplastic syndromes (MDS)
    Platzbecker, Uwe
    Meredyth-Stewart, Michelle
    Ehninger, Gerhard
    CANCER TREATMENT REVIEWS, 2007, 33 : S53 - S58
  • [28] Myelodysplastic syndromes (MDS) Preface
    Klimek, Virginia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2015, 28 (01) : 1 - 2
  • [29] LOW-DOSE ARA-C REGIMEN ADAPTED TO THE FAB-CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES (MDS) - IS IT SUPERIOR TO UNIFORM TREATMENT OF ALL TYPES OF MDS
    SCHLAG, R
    ZANKOVICH, R
    WALTHER, J
    FONATSCH, C
    THIELE, J
    HILL, W
    THIEL, E
    DIEHL, V
    BLUT, 1988, 56 (06): : C22 - C22
  • [30] The WHO classification of myelodysplastic syndromes (MDS) does make a difference.
    Howe, RB
    Porwit, A
    Wanat, R
    Tehranchi, R
    Hellstrom-Lindberg, E
    BLOOD, 2002, 100 (11) : 790A - 791A
12345